Labshake search
Citations for R&D Systems :
2851 - 2900 of 4407 citations for Human Nuclear Factor Of Activated T Cells 5 NFAT5 ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2022Quote: ... and recombinant human IL-2 20 ng/ml (202-IL, R&D Systems). The QCM Leukocyte Migration Assay (MilliporeSigma ...
-
bioRxiv - Microbiology 2023Quote: ... recombinant human Gas6 protein (R&D Systems, Minneapolis, MN, USA, cat# 885-GSB), recombinant mouse Gas6 protein (R&D Systems ...
-
bioRxiv - Cell Biology 2023Quote: ... Human Fc-fusion constructs of each receptor were purchased from R&D Systems (TGFβRII-Fc ...
-
bioRxiv - Genetics 2023Quote: ... recombinant human EGF at 20 ng/mL (R&D systems #236-EG-200), and recombinant human FGF2 at 20 ng/uL (R&D systems #233-FB-010).
-
bioRxiv - Immunology 2023Quote: Goat anti-human IL-1α (AF-200-NA) was from R&D Systems. Rabbit anti-human BirA (11582-RP01 ...
-
bioRxiv - Cell Biology 2023Quote: ... and goat anti-human CD144 (Cat. AF938, R&D Systems; dilution 1:250). After three washes with PBS ...
-
bioRxiv - Molecular Biology 2023Quote: ... Recombinant human (rh) TGF-β (10 ng/mL, R&D Systems, 7754-BH) was applied to NHLF cell line only to induce LOX expression ...
-
bioRxiv - Bioengineering 2023Quote: ... or 1000 ng/mL of recombinant human IFN-γ (R&D Systems, 285IF100) and TNF-α (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 μg/mL TrkB-Fc (Recombinant Human Chimera, 688-TK, R&D Systems) was injected intraventricularly ...
-
bioRxiv - Cancer Biology 2023Quote: ... Sections were then stained with goat anti-human IL-33 (R&D Systems, # AF3625 ...
-
bioRxiv - Immunology 2023Quote: ... mouse anti-human CCR1 (25 µg/ml; mab145, R&D Systems, Minneapolis, MN), rat anti-mouse CCR1 (25 µg/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant human SHH (high activity (R&D Systems: Cat # 8908-SH-005/CF), and fixed after indicated treatment durations and processed as described below ...
-
bioRxiv - Systems Biology 2023Quote: ... BTC at 40 ng/mL (human recombinant Betacellulin protein, R&D systems, MN), or combinations of all for 6 hours ...
-
bioRxiv - Bioengineering 2023Quote: ... or 4 µg mL-1 human PDGFR beta antibody (AF385, R&D Systems) and 10 µg mL-1 human/mouse/rat alpha-smooth muscle actin antibody (MAB1420 ...
-
bioRxiv - Genetics 2023Quote: ... The calibrator is recombinant human GDF15 from R&D Systems (Bio-Techne, USA). MSD Ansh antibody Total GDF15 between batch imprecision based on in-house sample pool controls 10.2% at 552.4 pg/ml ...
-
bioRxiv - Pathology 2023Quote: ... were treated with recombinant human osteopontin (rhOPN; R&D Systems, 1433-OP-050) for 24 hours in serum and supplement-free growth medium (EGM ...
-
bioRxiv - Physiology 2023Quote: ... Activity of BCAT was assessed using recombinant human BCAT2 (rhBCAT2; R&D Systems)41 ...
-
bioRxiv - Neuroscience 2023Quote: ... goat anti-Human DKK-3 (1:1,000, R&D Systems, Cat# AF1118, RRID:AB_354610), rabbit anti-GAPDH (1:5,000 ...
-
bioRxiv - Immunology 2023Quote: ... Anti-human IL-1β antibody (AF-201-NA) was from R&D Systems. Anti-murine IL-1β antibody (5129-100 ...
-
bioRxiv - Cell Biology 2023Quote: ... 50 ng/ml recombinant human Wnt3a (R&D Systems; day 1 and 2), 1 mM L-Glutamine (L-Glu ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Cancer Biology 2023Quote: ... Serum-deprived media ±recombinant human CCL8 or CCL15 (R&D Systems, Minnneapolis, MN) and ±5 μg/ml neutralizing antibodies for CCR1 ...
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
bioRxiv - Immunology 2024Quote: ... recombinant human IFN-γ (2 ng/ml) (285-IF-100, R&D Systems), recombinant human TNFα (10 ng/ml ...
-
bioRxiv - Cell Biology 2024Quote: ... and 50 IU/mL human IL-1β (R&D Systems; 201-LB-005). EndoC- βH1 cells were transfected using Accell siRNA targeted against human GOLM1 (Horizon Discovery) ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 50 ng/mL recombinant human M-CSF (R&D Systems 216-MC). M1 macrophage attachment medium was prepared using DMEM supplemented with 10% heat-inactivated FBS ...
-
bioRxiv - Cancer Biology 2024Quote: The human HGF Antibody was purchased from R&D systems (AB-294-NA); murine HGF recombinant protein was purchased from Sino Biological (50038-MNAH-20) ...
-
bioRxiv - Microbiology 2021Quote: ... The medium for differentiation consisted of DMEM/F12 supplemented with 5% R-Spondin1 conditioned medium (home made from Cultrex 293T R-spondin1-expressing cells, R&D Systems, MN, USA), 10% Noggin conditioned medium (home made with HEK293-mNoggin-Fc cells ...
-
bioRxiv - Molecular Biology 2020Quote: ... cells were washed twice with PBS and stimulated with cytokine cocktail consisting of IL-1β (5 ng/ml, R&D Systems, Minneapolis, MN, USA), and IFN-γ (50 ng/ml ...
-
bioRxiv - Cancer Biology 2020Quote: ... PBS or conditioned media from lung stromal cells from HFD-fed mice treated with 5 μg/mL of either CSF2 neutralizing antibodies (R&D Systems, MAB415-100) or rat IgG antibodies (R&D Systems ...
-
bioRxiv - Cell Biology 2022Quote: ... MDA-MB-231 and HEK293T cells (ATCC) were cultured in DMEM (4.5 g/liter glucose, pH 7.2) with 5% FBS (Atlanta Biologicals/R&D Systems #S11150, Lot #F18071) 20 mM Hepes ...
-
bioRxiv - Molecular Biology 2022Quote: ... Subsequently plates were washed 3 times with PBS-T and primary antibody (anti-RBD-mouse, R&D systems, Minneapolis, MN, USA) was added in a dilution of 1 ...
-
bioRxiv - Neuroscience 2019Quote: CXCL12 concentration in supernatants of CXCL12 Ch/DS NC was quantified using Mouse CXCL12 DuoSet ELISA as per supplier instructions (R&D systems, Minneapolis, USA). Encapsulation efficiency and drug loading were calculated as follow:
-
bioRxiv - Genomics 2020Quote: Plasma was used to assess circulating monocyte chemoattractant protein (MCP)-1 and C-reactive protein (CRP) via ELISA following manufacturer’s instructions (R&D Systems, Minneapolis, MN, USA) (1).
-
bioRxiv - Neuroscience 2019Quote: ... IL-6 concentrations in maternal blood plasma (3 hours post-injection) were determined using a rat-specific ELISA DuoSet (R&D Systems, Abingdon, UK) as reported elsewhere [27] ...
-
bioRxiv - Microbiology 2019Quote: ... Supernatants were harvested at the 24h post-treatment time point and analyzed for cytokine content using ELISA for IL-6 (R&D Systems; Minneapolis, MN) according to the manufacturer’s protocol
-
bioRxiv - Immunology 2019Quote: ... and the tissue levels of myeloperoxidase (MPO) in the supernatants were determined using a mouse MPO ELISA (R&D systems, Biotechne, Minneapolis, MN, USA). The fixed tissues (left lungs ...
-
Stromal STAT5-mediated trophic activity regulates hematopoietic multipotent progenitor niche factorsbioRxiv - Cell Biology 2022Quote: ... fresh DMEM medium with reduced FBS (2%) was changed and the supernatant was harvested 24 hr later for IGF-1 and SDF-1α ELISA assays (R&D Systems, Minneapolis, MN).
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... and WNT16 levels were determined in senescent fibroblast lysates using a standardized sandwich Enzyme-Linked Immunoassay (ELISA) technique (R&D Systems, Minneapolis, MN, USA), according to manufacturer’s protocol.
-
bioRxiv - Immunology 2023Quote: ... supernatants were harvested to measure the release of IFN-γ using a IFN-γ-specific ELISA according to the manufacturer’s instructions (R&D Systems, DY28B05). To evaluate T cell activation markers ...
-
bioRxiv - Physiology 2023Quote: ... Then the tumor necrosis factor alpha (TNFA) and interleukin 10 (IL10) protein levels in the tissue were measured by enzyme linked immunosorbent assay (ELISA) (R&D Systems, Abingdon, UK).
-
bioRxiv - Immunology 2023Quote: ... cell culture supernatants or sulcus fluid from patients with different disease stage were evaluated for MMP-9 content using ELISA Duo Set (DY911, R&D System, Wiesbaden, Germany.) following the manufactureŕs protocol.
-
bioRxiv - Physiology 2024Quote: ... 50 µL of murine plasma was then used to quantify glucagon concentrations with ELISA by following the manufacturer’s protocol (R&D Systems, cat no. DGCG0). Final glucagon concentrations were calculated based on a standard curve.
-
bioRxiv - Immunology 2020Quote: ... 5 µM SB431542 (1614/10, R&D Systems), 20 ng/ml FGF (100-18B ...
-
bioRxiv - Developmental Biology 2019Quote: ... and 5 ng/ml Noggin (R&D Systems). On Day 4 ...
-
bioRxiv - Immunology 2019Quote: ... 5 μg/mL recombinant mSAA1 (R&D Systems) was added to whole lamina propria samples during the PMA/ionomycin/brefeldin A stimulation ...
-
bioRxiv - Immunology 2022Quote: ... 5 ng/ml IL-4 (R&D Systems) and 12 ng/ml IL-10 (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... IFN-λ1 (5 ng/ml, R&D Systems), IFN-λ2 (60 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... 5 ng/ml IL-7 (R&D Systems), 5 ng/ml IL-15 (R&D Systems) ...
-
bioRxiv - Microbiology 2021Quote: ... ULBP-2/5/6 (65903, R&D systems), Plexin-B1 (rea728 ...